BMP-7 Fails to Attenuate TGF-beta1-induced Epithelial-to-mesenchymal Transition in Human Proximal Tubule Epithelial Cells
Overview
Nephrology
Affiliations
Background: In rodent models of chronic renal disease bone morphogenetic protein-7 (BMP-7) has been shown to halt disease progression and promote recovery. Subsequent studies utilizing immortalized rodent renal cell lines showed that BMP-7 was renoprotective by antagonizing TGF-beta1-stimulated epithelial-to-mesenchymal transition (EMT). The present study sought to determine if BMP-7 prevents TGF-beta1-induced EMT in primary (RPTEC) and immortalized (HK-2) human proximal tubule epithelial cells.
Methods: EMT was determined by quantitative real-time PCR analysis of e-cadherin, vimentin, CTGF and TGF-beta1 transcript expression and immunocytochemical analysis of ZO-1 and alpha-smooth muscle actin (alpha-SMA) protein expression following TGF-beta1 treatment in RPTEC and HK-2 cells.
Results: In RPTEC and HK-2 cells, TGF-beta1 significantly reduced e-cadherin expression and significantly increased vimentin, CTGF and TGF-beta1 expression. TGF-beta1 also diminished ZO-1 immunoreactivity and increased alpha-SMA expression in confluent cell monolayers. Co-incubation of TGF-beta1 with an anti-TGF-beta1 neutralizing antibody substantially reduced the cytokine's effects, which indicated EMT in these cells was inhibitable. Co-administration of BMP-7 over a broad concentration range (0.01-100 microg/ml) with TGF-beta1 failed to attenuate EMT in RPTEC or HK-2 cells, as demonstrated by no inhibition of altered e-cadherin, vimentin, CTGF and TGF-beta1 expression and no restoration of ZO-1 immunoreactivity. Furthermore, when BMP-7 was applied to proximal tubule cells alone, it also decreased e-cadherin expression and increased vimentin, CTGF and TGF-beta1 expression. Additionally, BMP-7 failed to induce the mesenchymal-to-epithelial transition (MET) in NRK-49F rat renal fibroblasts. BMP-7 did however prevent TGF-beta1-mediated e-cadherin downregulation in TCMK-1 mouse renal tubular epithelial cells. BMP-7 activity was routinely confirmed by examining BMP-7-induced phosphorylation of SMADs 1/5/8, BMP-7 regulation of BMPR-IA, BMP-7-mediated reduction of IL-6 transcript expression and BMP-7-mediated reduction of secreted IL-6 and IL-8 proteins.
Conclusions: In the present study, despite confirming BMP-7 regulation of receptor expression and induction of downstream signalling events, we were unable to demonstrate BMP-7 inhibition of EMT in either primary or immortalized human proximal tubule cells. Moreover, we were unable to demonstrate BMP-7-stimulated MET in rat renal fibroblasts. A protective effect was however observed at an elevated BMP-7 concentration in mouse renal tubular epithelial cells.
Wang T, Wagner R, Hlady R, Pan X, Zhao X, Kim S Mol Oncol. 2023; 18(1):44-61.
PMID: 37418588 PMC: 10766198. DOI: 10.1002/1878-0261.13487.
Fang X, He J, Chen Y, Ke B, Zhu S, Fan C Int Urol Nephrol. 2023; 55(7):1837-1846.
PMID: 36781680 DOI: 10.1007/s11255-023-03503-6.
Jin H, Wang Y, Wang D, Zhang L Evid Based Complement Alternat Med. 2018; 2018:4761925.
PMID: 29576795 PMC: 5822778. DOI: 10.1155/2018/4761925.
HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.
Matsuda H, Campion C, Fujiwara K, Ikeda J, Cossette S, Verissimo T Oncotarget. 2017; 8(41):69559-69576.
PMID: 29050225 PMC: 5642500. DOI: 10.18632/oncotarget.18012.
TGF-β Family Signaling in Ductal Differentiation and Branching Morphogenesis.
Kahata K, Maturi V, Moustakas A Cold Spring Harb Perspect Biol. 2017; 10(3).
PMID: 28289061 PMC: 5830900. DOI: 10.1101/cshperspect.a031997.